Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials

Autor:	Xiangxiang Zhang, Yinhui Mao, Yang Liu, Jilei Sun, Juntao Sun, Chenli Pan, Zhuo Wang, Zhitao Wei, Yong Yang
Zdroj:	Frontiers in Surgery; 2024, p1-26, 26p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu